BIO-Europe Spring® 2012 produced by EBD Group, the leading partnering firm for the life science industry, will be held in Amsterdam March 19-21, 2012 at the Amsterdam RAI Convention Center. The event will highlight the biotech and pharmaceutical community in The Netherlands, with a special emphasis on recent Dutch biotech deals and the power alliances that made them happen.
The conference program features a Monday morning workshop entitled "Close up and personal: Recent deals examined from both sides" moderated by Roel Bulthuis, Head of Merck Serono Ventures, that includes panelists Willem van Weperen with to-BBB technologies; Onno van de Stolpe with Galapagos; Rudy Mareel with Synthon; and Vincent de Groot with Synthon. Other deal-centric panels include one on examining major deals of the past year and another on strategies for overcoming the challenges of late state deals.
"The Netherlands is an ideal place for dealmaking and partnering opportunities due to their strong life sciences cluster and growth potential," said Carola Schropp, President, EBD Group. "The Netherlands bring a lot to the table in terms of novel drug development and innovative biotechnology, and international partnering is expected to gain in importance for the future growth of Dutch life science companies."
Home to Leiden Bio Science Park, the leading life sciences cluster, The Netherlands biotech and biomedical business sector offers opportunities for both start-ups and established companies including licensing and innovative research and development.
"The core value of Dutch companies is based on our strength to transform excellence in science into commercial success," said Onno van de Stolpe, CEO of Galapagos. "Partnering is key to the sector. Deals between biotech and big pharma are essential to provide credibility to investors and generate cash flow to fund research. As one of the premier partnering events in the world, BIO-Europe Spring is an important catalyst for forming the collaborations that drive the industry."
A report published in January 2012 by Life Sciences Health (LSH), the national cluster organization of the Dutch life sciences and health sector, reported 329 companies that employed 24,385 people between 2009 and 2010, with continued growth in the number of companies expected. The cluster also reported the expectation that partnerships or alliances will be a major source of future financial growth for Dutch companies followed by M&A. The report stated that the sector is growing steadily mainly due to an increase in small start-up companies, with large companies (ove 250 employees) still responsible for nearly 90% of the total revenue. A copy of the report can be downloaded at http://www.lifesciencesoutlook.com/.
Partnering opportunities generated by partneringONE®, the leading conference partnering system for the life sciences, are now open. Information on how to create a partnering profile and begin efficiently identifying and requesting meetings with potential collaborators can be found at http://www.ebdgroup.com/bes/partnering/index.php.
The online registration deadline for the conference is March 16, 2012, 13:00 CET, after which all registrations will be handled on site. Information on the conference and registration details can be found online at http://www.ebdgroup.com/bes/registration/index.php.
For more information about BIO-Europe Spring, go to www.ebdgroup.com/bes/index.php.
Additional links and information:
partnering360: www.partnering360.com
Follow BIO-Europe Spring 2012 on Twitter: twitter.com/EBDgroup (hashtag: #BES12)
LinkedIn Event site: http://linkd.in/uA0L0x
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group´s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group´s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe´s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America TM, the fastest growing partnering event in North America
- EuroMedtech TM, EBD Group´s partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities
- Biotech Showcase TM, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
EBD Group´s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences at industry events.
Outside of the conference format, EBD Group´s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies. EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
